CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

about

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

Item

http://www.wikidata.org/entity/Q48474028

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

@en

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

@nl

type

Item

label

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

@en

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

@nl

prefLabel

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

@en

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

@nl

P1476

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

@en

P2093

Alberto Calvi

http://www.w3.org/2001/XMLSchema#string

Barbara Spanò

http://www.w3.org/2001/XMLSchema#string

Emanuela Oldoni

http://www.w3.org/2001/XMLSchema#string

Fabio Triulzi

http://www.w3.org/2001/XMLSchema#string

Francesca Schiano di Cola

http://www.w3.org/2001/XMLSchema#string

Milena A De Riz

http://www.w3.org/2001/XMLSchema#string

Paola Basilico

http://www.w3.org/2001/XMLSchema#string

Sara Mg Cioffi

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging

Axonal transection in the lesions of multiple sclerosis

The clinico-radiological paradox in multiple sclerosis revisited.

Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.

Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.

Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.

Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis.

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis.

P304

1085-1091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458516674566

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27754941

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis